You have 9 free searches left this month | for more free features.

urine

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Fructose Intolerance Trial in Iowa City (Placebo, Alanine)

Recruiting
  • Fructose Intolerance
  • Placebo
  • Alanine
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
Jul 19, 2022

Stoma Ileostomy Trial in Kansas City (Stoma Boot Camp, Standard of Care)

Completed
  • Stoma Ileostomy
  • Stoma Boot Camp
  • Standard of Care
  • Kansas City, Kansas
    University of Kansas Medical Center
Sep 8, 2020

Ovarian Cancer Trial in Gothenburg (211-astatine MX35 F(ab')2)

Completed
  • Ovarian Cancer
  • 211-astatine MX35 F(ab')2
  • Gothenburg, Sweden
    Sahlgrenska University Hospital, Dept of Oncology
Jul 2, 2020

Healthy Volunteers Trial in Nijmegen (Endotoxin, Placebo, Adrecizumab)

Completed
  • Healthy Volunteers
  • Nijmegen, Gelderland, Netherlands
    Dept. of Intensive Care Medicine, Research-unit, Radboud univers
Jan 29, 2021

Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, Dystrophinopathy Trial in Worldwide (Ataluren)

Completed
  • Duchenne Muscular Dystrophy
  • +2 more
  • Parkville, Melbourne, Australia
  • +20 more
Nov 3, 2020

Stress Urinary Incontinence Trial in Haifa (Nolix Device)

Completed
  • Stress Urinary Incontinence
  • Nolix Device
  • Haifa, Israel
    Assuta Medical Center
Apr 5, 2020

Inflammation, Skin Abnormalities, Skin Pigment Trial in Halifax (Anti-Aging Formula, Control Fish Oil, Inert Placebo)

Withdrawn
  • Inflammation
  • +4 more
  • Anti-Aging Formula
  • +2 more
  • Halifax, Nova Scotia, Canada
    Cornerstone Naturopathic Clinic, 14 Old School Rd, Upper Tantall
Jul 14, 2020

Postprandial Blood Glucose, Gut Microbiota, Satiety Trial in Oslo (Saturated fat 14.9 E%, Polyunsaturated fat 13.6 E%)

Completed
  • Postprandial Blood Glucose
  • +2 more
  • Saturated fat 14.9 E%
  • Polyunsaturated fat 13.6 E%
  • Oslo, Norway
    Oslo Metropolitan University
May 6, 2020

Invasive Aspergillosis Trial in Nottingham (IV F901318, Oral F901318)

Withdrawn
  • Invasive Aspergillosis
  • IV F901318
  • Oral F901318
  • Nottingham, Nottinghamshire, United Kingdom
    Quotient Clinical
Jul 24, 2019

Eating Behavior Trial in Worldwide (Sweetener and sweetness enhancer consumption)

Recruiting
  • Eating Behavior
  • Sweetener and sweetness enhancer consumption
  • Copenhagen, Denmark
  • +4 more
Nov 5, 2021

Triple Negative Breast Cancer, Endometrial Cancer, Hormone Receptor Positive, HER2 Negative Breast Cancer Trial run by the

Completed
  • Triple Negative Breast Cancer
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 17, 2021

Hypertension Trial in United States (, PF-00489791)

Completed
  • Hypertension
  • Los Angeles, California
  • +19 more
Sep 13, 2021

Spontaneous Bacterial Peritonitis Trial in Foggia (Rifaximin, Norfloxacin)

Active, not recruiting
  • Spontaneous Bacterial Peritonitis
  • Foggia, Italy
    Ospedali Riuniti Foggia
Feb 15, 2021

Postmenopausal Osteoporosis Trial in Worldwide (Alendronate)

Completed
  • Postmenopausal Osteoporosis
  • Lakewood, Colorado
  • +24 more
Nov 18, 2020

Type 1 Diabetes Trial in Worldwide (MedtronicMinimed 670G 3.0 hybrid closed loop system, Medtronic Minimed 670G 4.0 AHCL with

Completed
  • Type 1 Diabetes Mellitus
  • MedtronicMinimed 670G 3.0 hybrid closed loop system
  • Medtronic Minimed 670G 4.0 AHCL with Guardian Sensor (3) continuous glucose monitoring sensor.
  • New Haven, Connecticut
  • +6 more
Apr 19, 2021

Head Neck Cancer, Xerostomia Trial in Shanghai (Acupuncture)

Unknown status
  • Head and Neck Cancer
  • Xerostomia
  • Acupuncture
  • Shanghai, China
    Fudan University Cancer Hospital
Dec 29, 2020

Cognitive Performance Trial in Bergen (Seafood, Non-seafood)

Completed
  • Cognitive Performance
  • Seafood
  • Non-seafood
  • Bergen, Norway
    NIFES
Nov 23, 2020

Drug Use Investigation for Toviaz

Completed
  • Overactive Bladder (OAB)
  • Fesoterodine (Toviaz)
  • (no location specified)
May 14, 2021

Respiratory Distress Syndrome in Premature Infants Trial (INSURE, LISA, Analgesic, Opioid)

Unknown status
  • Respiratory Distress Syndrome in Premature Infants
  • INSURE
  • +2 more
  • (no location specified)
Sep 1, 2020

Advantage ofFast-recovery Protocol for Minimally Invasive Kidney

Unknown status
  • Renal Cell Carcinoma
  • enhanced recovery after surgery program
  • Lille, France
    Hop Claude Huriez Chu Lille
Oct 19, 2020

Recurrent Urinary Tract Infection Trial (Intravesical antibiotic instillation, Antibiotic oral suppressive therapy)

Not yet recruiting
  • Recurrent Urinary Tract Infection
  • Intravesical antibiotic instillation
  • Antibiotic oral suppressive therapy
  • (no location specified)
Jan 13, 2021

Urge Urinary Incontinence Trial in Chapel Hill (Fesoterodine Fumarate)

Completed
  • Urge Urinary Incontinence
  • Fesoterodine Fumarate
  • Chapel Hill, North Carolina
    UNC-Chapel Hill, Dept of Ob/Gyn
Mar 16, 2020

Pharmacokinetics of Mirabegron, Food Effect, Healthy Chinese Subjects Trial in Shanghai (mirabegron)

Completed
  • Pharmacokinetics of Mirabegron
  • +2 more
  • Shanghai, China
    Site CN86001
Nov 10, 2021

Breast - Female Trial in Stanford (procedure, device, drug)

Completed
  • Breast - Female
  • Transversus Abdominis Plane (TAP) block
  • +6 more
  • Stanford, California
    Stanford University Medical Center
Aug 28, 2021

Cystic Fibrosis Trial in Verona (Teicoplanin Sandoz 200 mg powder and solvent for solution for injection or infusion or oral

Completed
  • Cystic Fibrosis
  • Teicoplanin Sandoz 200 mg powder and solvent for solution for injection or infusion or oral solution.
  • Verona, Italy
    Centro Ricerche Cliniche di Verona - Azienda Ospedaliera Univers
Dec 4, 2020